StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.33+0.10 (+1.38%)

Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%

Immunic total assets

Total assets on the balance sheet at the end of each period.

Immunic's total assets was $159.17M at Jun 30, 2026. For fiscal 2025 it was $24.05M, down 41.1% from the year before. Over ten years it grew -12.3% a year on average. The highest annual figure on record is $167.86M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.05M-41.1%
FY2024Dec 31, 2024$40.87M-24.7%
FY2023Dec 31, 2023$54.30M-57.5%
FY2022Dec 31, 2022$127.75M-8.2%
FY2021Dec 31, 2021$139.10M-17.1%
FY2020Dec 31, 2020$167.86M+154.5%
FY2019Dec 31, 2019$65.96M+393.3%
FY2018Dec 31, 2018$13.37M-77.9%
FY2017Dec 31, 2017$60.38M-5.7%
FY2016Dec 31, 2016$64.03M-28.1%
FY2015Dec 31, 2015$89.08M-17.6%
FY2014Dec 31, 2014$108.08M+132.0%
FY2013Dec 31, 2013$46.59M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$159.17M+159.1%
Q1 FY2026Mar 31, 2026$189.74M+824.9%
Q4 FY2025Dec 31, 2025$24.05M-41.1%
Q3 FY2025Sep 30, 2025$40.70M-37.1%
Q2 FY2025Jun 30, 2025$61.43M-29.0%
Q1 FY2025Mar 31, 2025$20.52M-80.3%
Q4 FY2024Dec 31, 2024$40.87M-24.7%
Q3 FY2024Sep 30, 2024$64.76M-3.3%
Q2 FY2024Jun 30, 2024$86.49M-2.5%
Q1 FY2024Mar 31, 2024$104.16M-4.3%
Q4 FY2023Dec 31, 2023$54.30M-57.5%
Q3 FY2023Sep 30, 2023$66.98M-44.7%
Q2 FY2023Jun 30, 2023$88.74M-36.0%
Q1 FY2023Mar 31, 2023$108.87M-27.4%
Q4 FY2022Dec 31, 2022$127.75M-8.2%
Q3 FY2022Sep 30, 2022$121.08M-22.8%
Q2 FY2022Jun 30, 2022$138.66M+1.9%
Q1 FY2022Mar 31, 2022$149.92M-3.1%
Q4 FY2021Dec 31, 2021$139.10M-17.1%
Q3 FY2021Sep 30, 2021$156.76M-8.7%
Q2 FY2021Jun 30, 2021$136.06M+56.1%
Q1 FY2021Mar 31, 2021$154.72M+170.1%
Q4 FY2020Dec 31, 2020$167.86M+154.5%
Q3 FY2020Sep 30, 2020$171.64M+153.9%
Q2 FY2020Jun 30, 2020$87.15M+20.1%
Q1 FY2020Mar 31, 2020$57.29M+446.6%
Q4 FY2019Dec 31, 2019$65.96M+393.3%
Q3 FY2019Sep 30, 2019$67.60M+238.2%
Q2 FY2019Jun 30, 2019$72.57M+108.5%
Q1 FY2019Mar 31, 2019$10.48M-77.7%
Q4 FY2018Dec 31, 2018$13.37M-77.9%
Q3 FY2018Sep 30, 2018$19.99M-71.6%
Q2 FY2018Jun 30, 2018$34.80M-56.9%
Q1 FY2018Mar 31, 2018$47.01M-48.3%
Q4 FY2017Dec 31, 2017$60.38M-5.7%
Q3 FY2017Sep 30, 2017$70.36M-2.9%
Q2 FY2017Jun 30, 2017$80.68M–
Q1 FY2017Mar 31, 2017$90.95M–
Q4 FY2016Dec 31, 2016$64.03M–
Q3 FY2016Sep 30, 2016$72.47M–

More Immunic figures

See a number that looks wrong?